Ambu A/S
Abonner på opdateringer Ambu A/S
Abonner på udvalgte opdateringer Ambu A/S ved at registrere din mailadresse nedenfor. Du kan altid opsige dit abonnement igen.
Anders HjortHead of Investor Relations
Tlf:+45 2892 8881anhj@ambu.comTine Bjørn SchmidtDirector of Corporate Communications
Tlf:+45 2264 0697tisc@ambu.comSince 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 5,000 people in Europe, North America, Latin America and Asia Pacific.
For more information, please visit Ambu.com.
- Ambu A/S
- Baltorpbakken 13
- 2750 Ballerup
- +45 7225 2000
- www.ambu.com
Selskabsmeddelelser
44
MenuKategori NasdaqAlle
ÅrAlle
AMBU’S SHARE BUYBACK PROGRAM HAS BEEN FINALIZED12.2.2026 09:37:21 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program was carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu has repurchased shares for a total amount of DKK 150m since 10 December 2025. The program had to be completed no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 09 February to 11 February 2026: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 1,673,984 86.0217 143,998,989 2026.02.09 0 0.0000 - 2026.02.10 0 0.0000 - 2026.02.11 72,050 83.2889 6
1 vedhæftning
TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM9.2.2026 08:56:46 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 02 February to 06 February 2026: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 1,475,270 86.2430 127,231,753 2026.02.02 116,000 84.6254 9,816,546 2026.02.03 70,000 84.0157 5,881,099 2026.02.04 0 0.0000 -
1 vedhæftning
INTERIM REPORT FOR Q1 2025/264.2.2026 07:04:05 CET | Ambu A/S | Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4% organically, mainly driven by strong Urology, ENT, & GI growth of 21.0%. Overall, Ambu delivered total organic revenue growth of 8.6% and a reported EBIT margin b.s.i. of 10.5%. The 2025/26 financial guidance is maintained. Growth and EBIT margin are still expected to be higher in H2 compared to H1. “We had a solid start to our 2025/26 financial year, with the launch of our ZOOM AHEAD strategy, setting a clear course for Ambu’s next phase of high, long‑term growth. Momentum in executing our strategy is high across the organization. I am pleased with our continued strong growth in Endoscopy Solutions, against high comparables from last year. In the Respiratory area, we have expanded our video laryngoscope portfolio with the introduction of Ambu® SureSight™ Mobile, our latest video laryngoscope solution. This innovation expands our Respiratory portfolio a
2 vedhæftninger
LAUNCH OF LONG-TERM INCENTIVE PLAN FOR EXECUTIVE MANAGEMENT AND KEY EMPLOYEES3.2.2026 09:43:54 CET | Ambu A/S | Other information disclosed according to the rules of the Exchange
Ambu A/S launches a new share based Long-Term Incentive Plan (LTIP) for its Executive Management and selected key employees for the 2025/26 financial year, pursuant to Ambu’s Remuneration Policy. The LTIP for 2025/26 has been approved by the Board of Directors. The LTIP is designed to align the interests of employees and shareholders, ensuring that employees are retained and rewarded for their dedicated efforts in achieving the company’s strategic and long-term objectives. The LTIP implies a target grant of a total of 266,170 (maximum 532,340) performance share units (PSUs) for 2025/26. Of these, 67,563 (maximum 135,126) PSUs are allocated to the Executive Management, while 198,607 (maximum 397,214) of the PSUs are allocated to other key employees. The grants will be issued with retroactive effect from 1 January 2026. For Executive Management, vesting of the PSUs is conditional upon achievement of key performance indicators (KPIs) relating to organic revenue growth and EBIT, measured a
1 vedhæftning
TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM2.2.2026 08:44:42 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 26 January to 30 January 2026: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 1,034,445 86.5836 89,565,949 2026.01.26 2,564 86.3954 221,518 2026.01.27 100,000 86.1475 8,614,750 2026.01.28 190,000 85.4863
1 vedhæftning
TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM26.1.2026 09:09:04 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 19 January to 23 January 2026: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 642,729 86.6685 55,704,338 2026.01.19 165,000 87.0499 14,363,234 2026.01.20 144,216 85.9114 12,389,798 2026.01.21 82,500 86.16
1 vedhæftning
TRANSACTIONS UNDER AMBU'S SHARE BUYBACK PROGRAM19.1.2026 09:46:06 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 12 January to 16 January 2026: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 640,807 86.6625 55,533,941 2026.01.12 0 0.0000 - 2026.01.13 1,532 88.3649 135,375 2026.01.14 0 0.0000 - 2026.01.15 0 0.0000 -
1 vedhæftning
TRANSACTIONS UNDER AMBU'S SHARE BUYBACK PROGRAM12.1.2026 10:09:13 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 05 January to 09 January 2026: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 577,453 86.6190 50,018,392 2026.01.05 39,862 86.9064 3,464,263 2026.01.06 0 0.0000 - 2026.01.07 9,777 87.4425 854,925 2026.01.
1 vedhæftning
REPORTING OF TRANSACTIONS MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES5.1.2026 13:04:48 CET | Ambu A/S | Managers' Transactions
In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units ("PSUs") to the Executive Management and other key employees. Reference is made to the company announcement of 28 July 2023 regarding the initial grant. Pursuant to the Market Abuse Regulation article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S’s shares admitted to trading and official listing on NASDAQ Copenhagen A/S. The attached document discloses the data of the transactions made by Executive Management. Company announcement no. 8 2025/26.
2 vedhæftninger
TRANSACTIONS UNDER AMBU'S SHARE BUYBACK PROGRAM5.1.2026 10:25:44 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 29 December 2025 to 02 January 2026: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 443,384 86.405 38,310,684 2025.12.29 1,069 88.2278 94,315.52 2025.12.30 33,000 87.9840 2,903,472.00 2025.12.31 - - - 202
1 vedhæftning
TRANSACTIONS UNDER AMBU'S SHARE BUYBACK PROGRAM29.12.2025 10:27:11 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 22 December to 26 December 2025: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 389,980 86.307 33,658,157 2025.12.22 52,200 87.1049 4,546,876 2025.12.23 1,204 87.7500 105,651 2025.12.24 - - - 2025.12.25 -
1 vedhæftning
TRANSACTIONS UNDER AMBU'S SHARE BUYBACK PROGRAM22.12.2025 09:43:33 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 15 December to 19 December 2025: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 150,000 85.778 12,867,960 2025.12.15 43,700 87.4031 3,819,515 2025.12.16 51,000 87.5344 4,464,254 2025.12.17 95,250 85.8411 8
1 vedhæftning
TRANSACTIONS UNDER AMBU'S SHARE BUYBACK PROGRAM15.12.2025 12:06:24 CET | Ambu A/S | Changes in company's own shares
On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations. During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR. The following transactions have been made under the program from 10 December to 12 December 2025: Number of shares Average purchase price, DKK Transaction value, DKK Accumulated under the program after last announcement 0 0 0 2025.12.10 50,000 85.5242 4,276,210 2025.12.11 48,000 85.5822 4,107,946 2025.12.12 52,000 86.2270 4,483,804 Accumulate
1 vedhæftning
INITIATION OF NEW SHARE BUYBACK PROGRAM10.12.2025 08:00:00 CET | Ambu A/S | Changes in company's own shares
Ambu A/S is initiating a new share buyback program under which Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The share buyback program is being launched within the authority granted by the shareholders at the annual general meeting held on 14 December 2022, for the repurchase of up to 10% of the company’s share capital, provided that the purchase price does not deviate by more than 10% from the most recently quoted market price for the company’s B-shares at the time of the acquisition. Prior to the launch of the share buyback program, Ambu holds 2,738,985 treasury shares, equal to 1.0% of the company’s share capital. The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations, with th
1 vedhæftning
DECISIONS OF THE ANNUAL GENERAL MEETING OF AMBU A/S4.12.2025 13:02:22 CET | Ambu A/S | Decisions of general meeting
Yesterday, 3 December 2025, Ambu A/S held its annual general meeting, at which the following items were adopted: Approval of the Company’s Annual Report and consolidated financial statements The presented audited Annual Report for the financial year 2024/25 was adopted by the shareholders. Approval of the Remuneration Report The proposed and presented Remuneration Report for the financial year 2024/25 was adopted by the shareholders. Approval of the appropriation of profit in accordance with the adopted Annual Report The Ambu Group reported a net profit for the year of DKK 609 million. The Board of Directors proposed a dividend of DKK 0.41 per share of nominally DKK 0.50 so that a dividend in the total amount of DKK 110 million be paid out of the net profit for the year, corresponding to 18% of the Group’s net profit, whereas the remaining part of the net profit be carried forward to next year. Approval of the Board of Directors' remuneration for the financial year 2025/26 The Board of
1 vedhæftning
REPORTING OF TRANSACTIONS MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES10.11.2025 13:21:35 CET | Ambu A/S | Managers' Transactions
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S. The attached document discloses the data of the transactions made by Executive Management. Company announcement no. 5 2025/26.
2 vedhæftninger
REPORTING OF TRANSACTIONS MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES7.11.2025 16:12:59 CET | Ambu A/S | Managers' Transactions
Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S. The attached document discloses the data of the transactions made by Executive Management. Company announcement no. 4 2025/26.
2 vedhæftninger
NOTICE OF ANNUAL GENERAL MEETING OF AMBU A/S7.11.2025 13:00:00 CET | Ambu A/S | Notice to general meeting
Notice is hereby given of the annual general meeting of Ambu A/S, CVR no. 63 64 49 19, which is held on Wednesday, 3 December 2025 at 3:00 pm (CET) at the company’s address at Baltorpbakken 13, 2750 Ballerup. BOARD OF DIRECTORS The Board of Directors proposes re-election of Jørgen Jensen as Chair of the Board and Shacey Petrovic as Vice Chair. The Board of Directors proposes that David Hale, Simon Hesse Hoffmann, Susanne Larsson, and Michael del Prado are all re-elected. The notice for this year’s annual general meeting, including information about the proposed Board candidates, is enclosed. This notice is available in Danish- and English-language versions. In the event of discrepancies, the English version shall prevail. Ambu A/S offers the possibility of viewing the annual general meeting 2025 via live webcast on Ambu’s website. Please refer to the notice for further information. Company announcement no. 3 2025/26.
3 vedhæftninger
ANNUAL REPORT 2024/255.11.2025 07:10:01 CET | Ambu A/S | Annual Financial Report
Today, Ambu releases its annual report for the 2024/25 financial year. For the full year, Ambu reported 13.1% organic revenue growth. This was driven by Endoscopy Solutions growing 15.4% and Anesthesia & Patient Monitoring growing 9.9%. Ambu’s EBIT margin before special items reached 13.0%, and the company’s free cash flow before acquisitions totaled DKK 407m. The financial outlook for the 2025/26 financial year is set as follows: 10-13% organic revenue growth and 12-14% reported EBIT margin before special items. Excluding tariff impacts of ~2%-pts, EBIT margin is expected to be 14-16% given the current schedule of expected tariffs. Mitigation action, including investing in Americas, are ongoing, and the effect will diminish over the coming years. “We have delivered another strong year at Ambu of double-digit organic growth and profitability, successfully concluding our turnaround with our ZOOM IN strategy and setting the stage for what’s next. We now are entering a new era of accelera
5 vedhæftninger
INTERIM REPORT FOR Q4 2024/25 AND OUTLOOK FOR FY 2025/265.11.2025 07:00:07 CET | Ambu A/S | Annual Financial Report
Solid growth in Q4 enables Ambu to close the financial year within the current guidance range, delivering 13.1% organic growth and a 13.0% EBIT margin. This consistent momentum highlights the resilience and strength of Ambu’s business model. Looking toward next year, Ambu expects 10-13% organic growth, driven by increased overall procedure volume and continued single-use conversion, and an EBIT margin of 12-14%, supported by continued operating leverage, though partially offset by short-term tariff costs. Excluding tariff impacts of ~2%-pts, EBIT margin is expected to be 14-16% given the current schedule of expected tariffs. Mitigation actions, including investing in Americas, are ongoing, and the effect will diminish over the coming years. “In line with our guidance, we delivered solid financial results, achieving 10.0% organic growth in Q4 and 13.1% for the full year. This performance was fueled by strong momentum in Endoscopy Solutions across all business areas, alongside extraordin
2 vedhæftninger
- 1
- 2
- 3
- Sidste
- >>
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 5,000 people in Europe, North America, Latin America and Asia Pacific.
For more information, please visit Ambu.com.
- Ambu A/S
- Baltorpbakken 13
- 2750 Ballerup
- +45 7225 2000
- www.ambu.com